coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Bury PCN, Bury (LAD) · Health Inequalities Profile

    PCN U49226 · NHS Greater Manchester Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    48,358

    Registered population

    62.1% aged 18–64

    14.5%

    Aged 65+

    ICB 14.9% · England 17.9%

    19.8%

    Ethnic minority (non-White)

    13.8% Asian · England 9.6%

    46.2%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~17,800

    Core20 residents (est.)

    Resident basis; registered basis ~23,388 · see page 3

    6,910

    Hypertension register

    +8.04% in 3 yrs · England +5.60%

    579

    SMI register

    23.2% of Bury (LAD)'s

    1,058

    COPD register

    Reviews +14.36% in 3 yrs

    Forecast to 2030

    8,162

    Hypertension patients, 2030

    +1,252 on today

    84.2%

    QRISK ≥20% on statins, 2030

    +5.80pp over 3 yrs

    3.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    1,190
    Asthma review coverage fell behind local and national.

    Asthma reviews fell -1.8% over 2023 to 2025 to 62.5% (England 65.7%, Bury (LAD) 64.2%), leaving a scale estimate of 1,190 patients unreviewed.

    76.2%
    Annual physical health checks lag for SMI patients.

    SMI blood pressure checks reached 76.2% (England 83.4%) and BMI checks 75.3% (England 82.1%), which may reflect recall gaps to test by audit.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A 23.4% child share and 13.8% Asian population may shape primary care demand

    Bury PCN serves 48,358 registered patients across eight practices. Children aged 0–17 comprise 23.4% of patients (11,319), above Bury (LAD) (21.1%), the ICB (21.8%) and England (19.6%). Conversely, 14.5% are aged 65+ (7,018 patients), below Bury (LAD) (17.6%), the ICB (14.9%) and England (17.9%). Census usual residents show 13.8% Asian or Asian British ethnicity, above Bury (LAD) (10.6%), the ICB (13.6%) and England (9.6%), alongside a 19.8% non-White population. Ethnicity reflects area residents rather than registered patients, while projected list growth of 0.8% to 2030 rests on unverified methodology.

    Age profile

    0–1723.4%
    18–6462.1%
    65+14.5%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White80.2%
    Asian13.8%
    Mixed2.5%
    Black2.1%
    Other1.5%

    Older people · falls rows are Bury (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bury LA)2,1392,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bury LA)1,0511,0219552024/25
    Falls deaths, all ages, per 100,000 (Bury LA)21.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 prevalence reaches 46.2% PCN-wide but spans 78.5 percentage points between member practices

    Core20 registered prevalence is 46.2% (average IMD decile 3.8), exceeding Bury (LAD) at 27.9%, the ICB at 40.7%, and England at 21.0%. Denominators require reconciliation before targeting: practice estimates sum to 23,388 patients, while resident deciles 1 and 2 total 17,800. Practice concentration spans 78.5 pp, led by Huntley Mount Medical Centre (78.51%) and Walmersley Road Medical Practice (72.79%), whereas volume concentrates at Rock Healthcare Limited (6,073 patients) and Radcliffe Medical Practice (5,364 patients). Reconciling these bases is needed to balance neighbourhood outreach with routine recall across member practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Huntley Mount78.5% · 2,075 patients
    Walmersley Road72.8% · 3,408 patients
    Knowsley68.5% · 3,029 patients
    Rock Healthcare65.5% · 6,073 patients
    Townside49.9% · 2,210 patients
    Radcliffe Medical46.9% · 5,364 patients
    Monarch34.9% · 1,229 patients
    Ramsbottom0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    579

    SMI register

    1.17% recorded prevalence

    296

    Learning disability register

    0.60% recorded prevalence

    27

    Care homes, 761 beds

    In the PCN catchment

    9.4%

    Provide unpaid care

    Bury (LAD), Census 2021

    The PCN records 579 patients on the severe mental illness register (1.2%) and 296 on the learning disability register (0.6%), with 27 catchment care homes holding 761 beds. Borough estimates show 5 rough sleepers and an unpaid carer ceiling of about 4,500.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.2% (England 1.0%). Annual physical checks trail comparators: blood pressure recording is 76.2% (England 83.4%, ICB 83.4%) and BMI recording is 75.3% (England 82.1%), which could reflect uneven recall; practice audit could test this.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,910

    Hypertension register

    +8.04%

    Register growth, 3 yrs

    Bury (LAD) +6.10% · England +5.60%

    +10.49pp

    BP control, under 80

    ≤140/90 · +6.97pp aged 80+

    +1,252

    More patients by 2030

    Forecast 8,162 (16.23%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 13.9% (6,910 patients), below England (15.2%), Bury (LAD) (15.2%) and NHS Greater Manchester ICB (14.4%). Over 2023 to 2025, prevalence rose +8.0% (+1.0 pp), outpacing England (+5.6%, +0.8 pp). Blood pressure control reached 70.3% treated to target, matching England (70.3%), alongside a 3-year gain of +9.5 pp (+15.7%). Across practices, prevalence spans from 7.3% at Walmersley Road Medical Practice and 7.8% at Rock Healthcare Limited to 23.5% at Townside Surgery. Observation periods are unstated, and crude rates do not establish unmet need. Lower recorded prevalence than comparators is consistent with variation in case finding, which clinical audit could test across practices reporting the lowest rates.

    Lipids and statins

    Lipid-lowering therapy exceeds benchmarks, with 71.1% of QRISK ≥ 20% patients treated (England 63.6%) and 80.4% in diabetes aged 40+ without CVD (England 73.2%). CKD coverage is 78.5% (England 70.3%). Higher coverage than England indicates strong preventive management, providing an opportunity to sustain proactive prescribing across all practices.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202690,768£2.10£1.94£1.86£190,613
    Cardiovascular (all), 2025109,109£3.80£3.15£3.33£414,614

    In 2026, the PCN prescribed 90,768 lipid-modifying items at £2.10 per item (England £1.86, Bury (LAD) £1.91, NHS Greater Manchester ICB £1.94), spending £21,784 more than at England's unit cost, which may reflect formulary mix rather than inefficiency; prescribing audit could test this. Higher unit cost than England highlights an opportunity to review lipid-modifying choices against ICB formularies.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −1.76%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.02%

    Asthma prevalence, PCN 3-yr % change

    COPD review coverage reached 83.5% (England 76.4%, Bury (LAD) 77.8%), with three-year growth of +14.4% (England +2.8%). Conversely, asthma review coverage is 62.5% (England 65.7%, Bury (LAD) 64.2%), with a three-year change of -1.8% (England +4.4%, Bury (LAD) +17.6%), leaving an estimated 1,190 of 3,171 registered patients unreviewed. Paediatric asthma prescribing reached 1,907 items per 1,000 aged 5-19 (England 1,488), while second-hand smoking status recording is 82.6% (England 78.8%). Lower asthma reviews despite high prescribing may indicate uneven recall, which practice audit could test.

    Cancer register and children's immunisation

    Cancer register prevalence is 2.8% (1,401 patients), below England (3.8%) and Bury (LAD) (4.0%). In Q1 2025/26, MMR1 coverage at age 5 reached 92.5% (England 91.7%), but MMR2 was 80.6% (England 82.8%), an 11.9 pp dose difference reaching 23.2 pp at Rock Healthcare Limited. Pre-school 4-in-1 booster coverage is 71.9% (England 80.9%), which record audit could examine.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.4%

    England 91.0%

    6-in-1 complete primary course at 24 months94.7%

    England 92.2%

    MMR dose 1 at 24 months90.9%

    England 88.3%

    MMR dose 2 at age 580.6%

    England 82.8%

    4-in-1 pre-school booster at age 571.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage were diagnosed at stage 1 or 2 (6,491 of 11,679), above England (55.3%) but 19.4 pp below the 75.0% national ambition by 2028. Staging was known for 70.8% of registered cancers (England 67.0%). In 2022, an estimated 2,268.2 extra early-stage cases would be required across the ICB to reach 75%. PCN recorded cancer prevalence is 2.8% (1,401 patients). Cervical screening coverage at ages 25-49 is 61.4% (Bury (LAD) 67.4%) and breast screening coverage at ages 53-70 is 68.7% (Bury (LAD) 73.8%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For the 62-day cancer referral to treatment standard, Bolton NHS Foundation Trust was 15.3 pp below the 85.0% standard, while NHS Greater Manchester Integrated Care Board was 9.3 pp below standard. On the 28-day faster diagnosis standard, Bolton NHS Foundation Trust exceeded the 75.0% standard by 5.5 pp, and NHS Greater Manchester Integrated Care Board exceeded it by 4.5 pp. On the 31-day combined treatment standard, Bolton NHS Foundation Trust exceeded the 96.0% standard by 0.5 pp, and NHS Greater Manchester Integrated Care Board exceeded it by 0.5 pp. These wider-system figures describe provider performance rather than PCN referrals.

    Pathways within standard (%)BoltonNorthern Care AllianceManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4875.2080.0679.5379.32
    31-day treatment (96%)96.5094.5492.5496.4992.50
    62-day referral to treatment (85%)69.6678.6572.8575.7371.16
    Diagnostic waits over 6 weeks (%)BoltonNorthern Care AllianceManchesterEngland
    MRI2.055.0911.6821.40
    CT19.404.1014.669.92
    Echocardiography3.4831.484.9128.48
    Colonoscopy1.3340.044.5130.83
    Gastroscopy2.0636.4829.3529.02
    All 15 DM01 tests15.7815.718.9823.14
    Community services activityBury residentsGreater Manchester ICB
    Care contacts58,875573,310
    Referrals7,43594,470
    Patients with a contact16,745183,535

    Community services (residents of Bury), Jun 2026 (provisional). In provisional data for June 2026, adults aged 65 and over accounted for 43.7% of community service contacts among Bury borough residents (25,735 of 58,875 contacts). These community-level figures describe resident activity across the local authority rather than PCN-specific activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice vaccination achievement spans 64.9 pp across member practices in 2025/26

    In 2025/26, QOF clinical-domain achievement was 100.0% at Walmersley Road Medical Practice. Vaccination and immunisation achievement spanned 64.9 pp, from 15.6% at Knowsley Medical Centre, Rock Healthcare Limited, and Walmersley Road Medical Practice to 80.5% at Ramsbottom Medical Practice (England 55.2%). Rock Healthcare Limited reported a 19.6% personalised care adjustment rate across all domains.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Radcliffe Medical11346.968.5%80.3%87.5%
    Knowsley10168.559.3%83.2%78.7%
    Walmersley Road10872.857.1%77.2%76.3%
    Huntley Mount10578.578.6%60.9%76.0%
    Townside Surgery9549.969.9%71.1%71.7%
    Ramsbottom1050.046.2%58.7%65.3%
    Monarch9734.954.2%77.3%63.9%
    Rock Healthcare9165.538.4%75.7%55.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBury (LAD)AssetPCNBury (LAD)
    Care homes (catchment)27 (761 beds)n/aSchools (catchment)85n/a
    Children's centres48Places of worship46107
    Libraries512Primary schools (LA maintained)1125
    Primary academies1533Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured annual asthma review recall

    Asthma review coverage is 62.5% (England 65.7%, Bury (LAD) 64.2%, ICB 66.2%) after falling 1.8% (1.1 pp) over 2023 to 2025, leaving a scale estimate of 1,190 of 3,171 patients unreviewed. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Dementia register coding and care-home audit

    Recorded dementia prevalence is 0.6% (287 patients) against 0.8% in England and 0.9% in Bury (LAD), giving an unadjusted benchmark gap range of +91 to +143 patients across the 48,358 list. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Option 3

    Combined SMI annual physical health checks

    Across the 579 patients on the SMI register (1.2% prevalence), 12-month blood pressure recording is 76.2% (England 83.4%, Bury (LAD) 77.9%, ICB 83.4%) and BMI recording is 75.3% (England 82.1%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally adapted primary care outreach (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension case finding review (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school second dose MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Dementia register coding and care-home audit (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Option 3 · Combined SMI annual physical health checks (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15